Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Health Tech
Biotech
FDA unveils plan for real-time review of clinical trial data
The FDA is testing allowing its reviewers to access information from clinical trials in real time, with AstraZeneca and Amgen already on board.
Darren Incorvaia
Apr 28, 2026 1:52pm
Lilly pens $2.2B gene editing pact with Bezos-backed Profluent
Apr 28, 2026 8:40am
Fierce Pharma
Merck goes with Google for AI push, strikes $1B enterprise deal
Apr 22, 2026 10:12am
OpenAI launches biotech-specific AI model dubbed GPT-Rosalind
Apr 17, 2026 10:00am
Small pools, big ideas: Rare disease community reimagines trials
Apr 17, 2026 3:00am
Fierce Pharma
Novartis CEO Vas Narasimhan joins Anthropic's board
Apr 15, 2026 10:36am